Brochure
1 Sep 2026
KAIVEXIN (Enoxaparin PFS with Sycure AD)
PDF 4.5 MB
The Efficacious Enoxaparin with Sycure AD Advantage
- Prevents misuse of PFS
- Individual always receives the right dosage of Enoxaparin
- Helps to reduce human error
- USDMF grade API
- Ease of administration
Content provided by our supplier
Kaisha Lifesciences Pvt. Ltd
-
Country/Region:India
-
On CPHI since:2019
-
Employees:25 - 49
Company types
Primary activities
Other Content from Kaisha Lifesciences Pvt. Ltd (3)
-
Brochure Pipeline Products with Dossier Readiness Timelines (2027)
General Category SVP's in the Pipeline for 2027 -
Brochure Kaisha Lifesciences - Presentation and Current Portfolio
• CDMO / CMO for Injectable Finished Formulations • Ready CTD Dossiers with Zone IVb Stability • New Product Development
-
Brochure Sovereign Pharma - Presentation
• 100% Contract Manufacturing Facility for SVP's. • We supply over 350 million injections globally. • Approved by EU, PIC/s, UKMHRA